These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4273812)

  • 1. Potential chemotherapeutic agents. Formation of 2,7-naphthyridones from nicotinamide derivatives.
    Palfreyman MN; Wooldridge KR
    J Chem Soc Perkin 1; 1974; 1():57-61. PubMed ID: 4273812
    [No Abstract]   [Full Text] [Related]  

  • 2. Nuclear magnetic resonance studies on pyridine dinucleotides. 6. Dependence of the 13C spin--lattice relaxation time of 1-methylnicotinamide and nicotinamide adenine dinucleotide as a function of pD and phosphate concentration.
    Riddle RM; Williams TJ; Bryson TA; Dunlap RB; Fisher RR; Ellis PD
    J Am Chem Soc; 1976 Jul; 98(14):4286-90. PubMed ID: 6501
    [No Abstract]   [Full Text] [Related]  

  • 3. Nuclear magnetic resonance studies on pyridine dinucleotides. I. The pH dependence of the carbon 13 nuclear magnetic resonance of nicotinamide adenine dinucleotide.
    Ellis PD; Fisher RR; Dunlap RB; Zens AP; Bryson TA; Williams TJ
    J Biol Chem; 1973 Nov; 248(22):7677-81. PubMed ID: 4356257
    [No Abstract]   [Full Text] [Related]  

  • 4. [1,8-Naphthyridine-derivatives from dehydrogenative cyclization (author's transl)].
    Möhrle H; Specks F
    Arch Pharm (Weinheim); 1975 Jul; 308(7):499-512. PubMed ID: 1164172
    [No Abstract]   [Full Text] [Related]  

  • 5. Substituent effects on pyridinium ring-opening reactions. Facile ring opening of 1-(N,N-dimethylcarbamoyl)nicotinamide cation.
    Johnson SL; Morrison DL
    Biochemistry; 1970 Mar; 9(6):1460-70. PubMed ID: 4313885
    [No Abstract]   [Full Text] [Related]  

  • 6. Naphthyridines. 3. Preparation of pyrimido[1,2-a]-and imidazo-[1,2-a]-[1,8]naphthyridines from 2-amino-1,8-naphthyridines.
    Harper JF; Wibberley DG
    J Chem Soc Perkin 1; 1971; 18():2985-91. PubMed ID: 5165377
    [No Abstract]   [Full Text] [Related]  

  • 7. Naphthyridines. IV. Preparation of anthyridines and pyrimido-[4,5-beta][1,8]naphthyridines from 2-amino-1,8-naphthyridines.
    Harper JF; Wibberley DG
    J Chem Soc Perkin 1; 1971; 18():2991-4. PubMed ID: 5165378
    [No Abstract]   [Full Text] [Related]  

  • 8. The naphthyridines.
    Paudler WW; Kress TJ
    Adv Heterocycl Chem; 1970; 11():123-75. PubMed ID: 4907463
    [No Abstract]   [Full Text] [Related]  

  • 9. 31 P and 13 C nuclear magnetic resonance studies of nicotinamide-adenine dinucleotide and related compounds.
    Blumenstein M; Raftery MA
    Biochemistry; 1972 Apr; 11(9):1643-8. PubMed ID: 4402157
    [No Abstract]   [Full Text] [Related]  

  • 10. Antivertigo agents. V. Quantitative structure-activity relationships of 6-[2-(4-aryl-1-piperazinyl)ethyl]-5,6,7,8-tetrahydro-1,6-naphthyridine s.
    Shiozawa A; Kogo Y; Ichikawa Y; Komuro C; Ishikawa M; Kurashige S; Miyazaki H; Yamanaka H; Sakamoto T
    Chem Pharm Bull (Tokyo); 1985 Dec; 33(12):5332-40. PubMed ID: 3833382
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of the primary acid modification reaction of reduced diphosphopyridine nucleotide models.
    Kim CS; Chaykin S
    Biochemistry; 1968 Jun; 7(6):2339-50. PubMed ID: 4298221
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel synthesis of 7-fluoro-8-(trifluoromethyl)- 1H-1,6-naphthyridin-4-one derivatives: intermolecular cyclization of an N-silyl-1-azaallyl anion with perfluoroalkene and subsequent intramolecular skeletal transformation of the resulting pentasubstituted pyridines.
    Suzuki H; Sakai N; Iwahara R; Fujiwaka T; Satoh M; Kakehi A; Konakahara T
    J Org Chem; 2007 Jul; 72(15):5878-81. PubMed ID: 17602590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of antimicrobial agents. VI. Studies on the synthesis of furo[3,2-b][1,8]naphthyridine derivatives.
    Hayakawa I; Suzuki N; Suzuki K; Tanaka Y
    Chem Pharm Bull (Tokyo); 1984 Dec; 32(12):4914-22. PubMed ID: 6534540
    [No Abstract]   [Full Text] [Related]  

  • 14. Models for the pyridine nucleotide coenzymes. Synthesis and properties of bridged dinicotinamide derivatives.
    Dittmer DC; Blidner BB
    J Org Chem; 1973 Aug; 38(16):2873-82. PubMed ID: 4270135
    [No Abstract]   [Full Text] [Related]  

  • 15. Pyridonecarboxylic acids as antibacterial agents. VIII. An alternative synthesis of enoxacin via fluoronicotinic acid derivatives.
    Miyamoto T; Egawa H; Matsumoto J
    Chem Pharm Bull (Tokyo); 1987 Jun; 35(6):2280-5. PubMed ID: 3478152
    [No Abstract]   [Full Text] [Related]  

  • 16. The electronic spectra of the isomers of reduced l-alkyl-nicotinamide.
    Maggiora G; Johansen H; Ingraham LL
    Arch Biochem Biophys; 1969 May; 131(2):352-8. PubMed ID: 4239603
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure and properties of the acetone adducts of 1-n-propyl nicotinamide iodide.
    Ludowieg J; Bhacca N; Levy A
    Biochem Biophys Res Commun; 1964; 14():431-6. PubMed ID: 4220836
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis of 1,8-naphthyridine derivatives. Potential antihypertensive agents. II.
    Da Settimo A; Ferrarini PL; Mori C; Primofiore G; Subissi A
    Farmaco Sci; 1986 Nov; 41(11):827-38. PubMed ID: 2879740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of new analgetic homopyrimidazoles.
    Mészáros Z; Knoll J; Szentmiklósi P; Dávid A; Horváth G; Hermecz I
    Arzneimittelforschung; 1972 May; 22(5):815-29. PubMed ID: 5068203
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on biologically active haloganenated compounds. III. Synthesis and antibacterial activity of 7-fluoromethyl-1,8-naphthyridine and quinoline derivatives.
    Tani J; Mushika Y; Yamaguchi T
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3517-29. PubMed ID: 7160009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.